Organization
University of Southern California Norris Comprehensive Cancer Center
7 abstracts
Abstract
Randomized phase II trial of dabrafenib and trametinib with or without navitoclax in patients (pts) with BRAF-mutant (MT) metastatic melanoma (MM) (CTEP P9466).Org: New York University School of Medicine, The Ohio State University Comprehensive Cancer Center, Duke University Medical Center, Northwestern University, University of Colorado Comprehensive Cancer Center,
Abstract
First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) in patients (pts) with microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): 64-month (mo) follow-up from CheckMate 142.Org: University of Southern California Norris Comprehensive Cancer Center, MD Anderson Cancer Center, University Hospitals Gasthuisberg/Leuven and KU Leuven, Hospital Universitario Virgen del Rocio, Westmead Hospital,
Abstract
Prostate-specific antigen value at 3 & 7 months (PSA-3mo, PSA-7mo) and overall survival (OS) in metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen deprivation (ADT) with or without orteronel (SWOG S1216).Org: University of California Davis Comprehensive Cancer Center, SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Cleveland Clinic Taussig Cancer Instititute,
Abstract
Bone biomarkers and subsequent survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): Results from the phase III SWOG S1216 trial of androgen deprivation +/- orteronel.Org: University of California Davis Comprehensive Cancer Center, SWOG Statistical Center, Western Human Nutrition Research Center, WHNRC, Davis Comprehensive Cancer Center,
Abstract
Outcomes of Black (B) versus White (W) patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen deprivation therapy (ADT) with or without orteronel (Ort): Analysis of pt-level data from SWOG-1216 phase 3 trial.Org: Huntsman Cancer Institute at the University of Utah, University of Utah/Huntsman Cancer Institute, Cleveland Clinic Taussig Cancer Instititute, SWOG Statistics and Data Management Center, Seattle, WA, Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center,
Abstract
Examining ultrafine particle pollution and lung cancer risk in a large, diverse cohort.Org: Keck School of Medicine of University of Southern California, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, University of Southern California Norris Comprehensive Cancer Center, Department of Environmental and Occupational Health Sciences, University of Washington, Population Sciences in the Pacific Program, University of Hawaiʻi Cancer Center,
Abstract
Long-term outcomes of PD-1 blockade in metastatic or unresectable cutaneous squamous cell cancer.Org: USC Keck School of Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, Scripps MD Anderson Cancer Center, Roswell Park Comprehensive Cancer Center, University of Southern California Norris Comprehensive Cancer Center,